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Ethanol consumption during pregnancy may induce profound changes in fetal CNS development. We postulate that some of the
effects of ethanol on striatal glutamatergic transmission and neurotrophin expression could be modulated by allopregnanolone, a
neurosteroid modulator of GABAA receptor activity. We describe the acute pharmacological effect of allopregnanolone (65𝜇g/kg,
s.c.) administered to juvenile male rats (day 21 of age) on the corticostriatal glutamatergic pathway, in both control and
prenatally ethanol-exposed rats (two ip injections of 2.9 g/kg in 24% v/v saline solution on gestational day 8). Prenatal ethanol
administration decreased the K+-induced release of glutamate regarding the control group. Interestingly, this effect was reverted
by allopregnanolone. Regarding BDNF, allopregnanolone decreases the content of this neurotrophic factor in the striatum of
control groups. However, both ethanol alone and ethanol plus allopregnanolone treated animals did not show any change regarding
control values. We suggest that prenatal ethanol exposure may produce an alteration of GABAA receptors which blocks the GABA
agonist-like effect of allopregnanolone on rapid glutamate release, thus disturbing normal neural transmission. Furthermore, the
reciprocal interactions found between GABAergic neurosteroids and BDNF could underlie mechanisms operating during the
neuronal plasticity of fetal development.
1. Introduction
Maternal alcohol consumption during pregnancy induces
profound changes in the development of the central nervous
system (CNS) in offspring [1]. Although the most critical
birth defect associated with alcohol consumption is fetal
alcohol syndrome (FAS) [2], many children who were pre-
natally exposed to alcohol do not present the morphological
brain changes characteristically seen in FAS, yet they may
still exhibit many of the mental dysfunctions induced by
ethanol [3]. Problems characteristically associated with this
pathology include impaired cognitive and motor skills, with
a reduction in general intellectual functioning, deficits in
verbal learning, spatial memory, and reasoning [4].
The basal ganglia appear to be sensitive to prenatal
ethanol exposure, as they are clearly smaller in children that
suffer from FAS [1]. The corpus striatum, a component of the
basal ganglia, is a critical brain structure involved in motor,
perceptual, and cognitive skills [5, 6]. It is innervated by
excitatory glutamatergic and inhibitory GABAergic neurons.
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The function of these nerve terminals is finely modulated
by neurotransmitters and by neurotrophic factors acting on
their specific receptors, the expression of which is altered
by prenatal exposure to ethanol [7, 8]. Although the most
common way to stimulate the receptors for glutamate and
GABA is the ligands themselves, an interesting kind of
molecules called neurosteroids may act as modulators of
ion channels-coupled receptors and thereby also mediate
neuronal responses [9, 10].
Recently, neurosteroids have received much attention
as neuroprotective agents against different injuries affecting
the CNS [11]. These effects could be modulated, among
others, via neuromodulation of GABAergic transmission
and less directly by modifying neurotrophin expression, a
notion supported by the fact that inducible neurotrophins
are downregulated by GABA activity [12]. Recent research
shows that allopregnanolone (3𝛼-hydroxy-5𝛼-pregnan-20-
one), a potent positive modulator of GABAA and glutamate
receptors activity [13], brain concentration is particularly
affected by ethanol administrations in rats [14]. Also, nerve
growth factor (NGF) and brain-derived neurotrophic factor
(BDNF), members of the neurotrophin family, protect neu-
rons from insults and regulate synaptic transmission in the
corpus striatum [15, 16].
Previous reports show that acute ethanol intoxication
of rat embryos on gestational day 8 produces postnatal
impairments in the neuronal function [17, 18]. In this study
we work with a similar experimental paradigm, ethanol
intoxication of rat embryos on gestational day 8, in order to
study potential modifications of glutamatergic and GABAer-
gic neurotransmission. We postulate that the neurosteroid
allopregnanolone administered on postnatal day 21 can possi-
bly override the damaging effect of ethanol by (1) interaction
of the neurosteroid allopregnanolone with glutamatergic and
GABAergic systems in striatum and (2) modifications of
expression of the neurotrophin BDNF. Both results allow us
to postulate the use of neurosteroids as potentially useful
molecules in neuroregeneration after brain damage induced
by prenatal ethanol exposure.
2. Materials and Methods
2.1. Reagents. The used reagents were as follows: ethanol
(Biofarma); allopregnanolone (Sigma, St. Louis, MO, USA);
(3H)-glutamic acid (3H-Glu); (3H)-𝛾-aminobutyric acid (3H-






glucose buffer (KRB, pH 7.4) orMg2+-free KRB (experiments
with 3H-Glu); BDNF Emax ImmunoAssay System kits from
Promega (Madison, WI, USA).
2.2. Animals and Prenatal Exposure to Ethanol. The proce-
dure used to expose rats to ethanol on gestational day 8 (GD8)
has been previously described [19]. Adult male and female
Sprague-Dawley rats (280–300 g) from our own breeding
colony were used. Animals for these experiments were kept
and handled according to the Guide for the Care and
Use of Laboratory Animals, Institute of Laboratory Animal
Research, Commission on Life Sciences, National Research
Council, USA [20]. All efforts weremade tominimize animal
suffering. They were housed under a constant temperature of
22 ± 1
∘C and a standard light/dark cycle (12 h light schedule
lights on at 07:00 a.m.) and controlled environmentwith food
and water ad libitum. Samples for vaginal smears were taken
daily from 09:00 to 10:00 a.m. Only rats that showed more
than two normal 4-5-day consecutive estrus cycles were used
for the experiments. On the evening of proestrus, they were
housed overnight with male rats. Presence of spermatozoa
in vaginal smears the following morning was interpreted as
an index of pregnancy and was referred to as gestational
day 1 (GD1). On GD8 animals were randomly divided into
two groups: one of them received two intraperitoneal (ip)
injections of ethanol (2.9 g/kg in 24% v/v saline solution),
spaced by an interval of 4 h, and the other one received an
identical volume of the saline, also spaced by a 4 h interval
(control). Delivery day was considered as postnatal day 1
(P1). All litters were normalized to 10–12 pups/rat and were
maintained until postnatal day 21 (P21). On P21 only male
pups were selected for the experimental protocol.
2.3. Neurosteroid Treatment. On P21, ethanol and control
males pups (𝑛 = 6–9) were s.c. injected with allopregnanol-
one (65 𝜇g/kg) dissolved in propylene glycol (0.2mg/mL)
or with the same volume of vehicle. Allopregnanolone was
initially dissolved in propylene glycol to a concentration of
600𝜇M. The dose of allopregnanolone used in the exper-
iments (65 𝜇g/kg) was obtained by successive dilution in
sterile saline.We selected this dose because it is approximately
two hundred times higher than in serum concentration
obtained in the night of proestrus in intact female rats [21].
After 2.5 h they were decapitated and the brains were rapidly
removed. The corpus striatum was immediately dissected
out on ice for release experiments. For neurotrophin content
measures, the striatumwas removed and stored at−80∘Cuntil
the day of the measurement procedure.
2.4. Release Experiments. Dissected striatal samples from6–9
rats were sliced at 240𝜇mwith aMcIlwain tissue chopper and
6 to 8 slices (experimental tissue) were exposed to 2.79𝜇M
(3H)-glutamic acid (3H-Glu) (specific activity 44Ci/mmol)
or 940 nM (3H)-𝛾-aminobutyric acid (3H-GABA) (specific





) Krebs-Ringer bicarbonate glucose buffer (KRB,
pH 7.4) or Mg2+-free KRB (experiments with 3H-Glu), for
15min at 37∘C. Slices were transferred to perfusion chambers
and superfused at a flow rate of 0.7mL/min with KRB
for 30min to remove nonincorporated neurotransmitter
(washing period). After that 5 fractions of samples (2min
each) were collected and considered as basal release. There-
after, a depolarizing concentration of K+ (KCl 28mM) was
introduced by addition in the superfusion system for a 6min
period. Fractions collected during this time were considered
as stimulated release. At the end of the experiment, slices
were homogenized in 2mL 0.2N perchloric acid in order to
obtain the total amount of radioactivity loaded by the tissue.
Aliquots of 500 𝜇L of the samples and homogenized tissue
were mixed with scintillation solution. The radioactivity of























































Figure 1: Panel (a): 3H-Glu uptake from rat striatal slices; Panel (b): 3H-Glu fractional release induced from rat striatal slices by 28mM K+.
Control (white bars) or prenatal ethanol-exposed (gray bars) male rats were injected with allopregnanolone (65𝜇g/kg) or vehicle on P21, 2.5 h
before the experiment. Results are expressed as mean ± SEM (𝑛 = 6–9) (different letters indicate statistically significant differences).
collected fractions and tissue samples was determined, and
the percentage of stimulus-evoked release of 3H-Glu or 3H-
GABA was calculated as the percentage of increase over
baseline after stimulation [22].
2.5. ELISA Assays. ELISA assessments for brain-derived
neurotrophic factor (BDNF) were performed using BDNF
Emax ImmunoAssay System kits from Promega (Madi-
son, WI, USA). Neurotrophin protein content of striatum
was obtained from 4-5 rats. Each ELISA 96-well plate
was coated with anti-BDNF monoclonal antibody (1 : 1000;
100 𝜇L/well) in carbonate coating buffer (0.05M sodium
bicarbonate/carbonate; pH 9.7). The wells were sealed with a
plate sealer and incubated overnight at 4∘C. On the following
day, the content of the wells was removed and the plates were
washed with Tris-buffered saline with Tween (TBST; 20mM
Tris-HCl, pH 7.6; 150mMNaCl; 0.05% v/v Tween-20).There-
after they were incubated at room temperature (RT) for
1 h in block and sample buffer (BSB, 200𝜇L/well). Tissue
samples were weighed, homogenized in 1 : 50 Dulbecco’s
phosphate-buffered saline (DPBS; pH 7.35), and centrifuged
for 15min (13000 rpm). Two columns on the ELISA plates
were designated for the neurotrophin standard curve, which
ranged from 0 to 500 pg/mL. A 200𝜇L aliquot of the tissue
sample was added to a well and 3 successive 1 : 2 dilutions
were made. Samples and standards were incubated for 6
hours, washed, and then incubated overnight at 4∘Cwith anti-
NGF or anti-BDNF antibodies. At the end of the procedure,
plates were washed and incubated with an anti-rat IgG-HRP
conjugate for 2.5 h at RT. After the incubation, TMB one
solution (tetramethylbenzidine and the peroxidase substrate)
was added to each well, and the plates were shaken for
5–10min at RT; the reaction was terminated by adding
1NHCl to the wells. The plates were read at 450 nm using a
monochromator microplate reader (Safire 2 Team), and the
results were normalized per gram of tissue assayed [23].
2.6. Statistical Analyses. Data were expressed as the mean
± SEM and analyzed using a two-way analysis of variance
parametric test (ANOVA 2), followed by a post hoc test
whenever necessary (Newman-Keuls test). 𝑃 < 0.05 was
considered as the minimum criterion for assigning statistical
significance.
3. Results
3.1. The Effect of Allopregnanolone on Striatal 3H-Glutamate
Uptake and Release in Male Rats Prenatally Exposed to
Ethanol. As an index of the activity of the glutamatergic
neurons, induced by prenatal ethanol treatment and acute
postnatal pharmacological treatment with allopregnanolone
we measured changes in the uptake and release of glutamic
acid from corpus striatum slices obtained from the animals
that received or did not receive prenatal ethanol. No change in
striatal 3H-Glu uptake was observed after prenatal exposure
to ethanol (Figure 1(a)). On the other hand, both control and
prenatal ethanol-exposed rats injected s.c. with 5 allopreg-
nanolone decreased the 3H-Glu uptake (𝑃 < 0.05) in relation
to the vehicle injection alone (Figure 1(a)). A clear decrease
of 3H-Glu release was found in response to the depolarizing
stimulus in the prenatal ethanol-exposed rats (Figure 1(b)).
The injection of allopregnanolone significantly decreased the
stimulus-evoked release of 3H-Glu in control rats (𝑃 <
0.01). Interestingly, the opposite trend is observed in the
prenatal ethanol-exposed rats injectedwith allopregnanolone
(Figure 1(b)).
3.2. The Effect of Allopregnanolone on Striatal 3H-GABA
Uptake and Release in Male Rats Prenatally Exposed to
Ethanol. As an index of the activity of the GABAergic
neurons, induced by prenatal ethanol treatment and acute
postnatal pharmacological treatment with allopregnanolone,


























Figure 2: Effect of allopregnanolone (65 ug/kg) on BDNF content in
P21 rat striatum. Control (white bars) or prenatal ethanol-exposed
(gray bars) male rats were injected with allopregnanolone or vehicle
on P21, 2.5 h before the experiment. Results are expressed as mean
± SEM (𝑛 = 4-5) (different letters indicate statistically significant
differences).
we measured changes in the uptake and release of GABA
from corpus striatum slices obtained from the animals that
received or did not receive prenatal ethanol. 3H-GABA
uptake did not change under different experimental condi-
tions. Also, no changes in striatal 3H-GABA stimulus-evoked
release were found after exposure to ethanol or after acute
allopregnanolone administration to the rats.
3.3. The Effect of Allopregnanolone on BDNF Concentrations
in Prenatally Ethanol-Exposed Rat Brain. As an index of
neurotrophin participation in the changes of the activity of
glutamatergic neurons induced by prenatal ethanol and by
allopregnanolone administration, we measured the changes
in BDNF protein content in brain tissues that are known to
have the receptors for these neurotrophins. Allopregnanolone
significantly decreasedBDNF levels in striatumof control rats
(𝑃 < 0.05) but not in ethanol-exposed rats (Figure 2).
4. Discussion
Herein we report that in control rats the administration of
allopregnanolone in a single subcutaneous dose decreases the
K+-induced release of glutamate from corpus striatum slices
in vitro (Figure 1(b)) and decreases the BDNF protein content
in this structure (Figure 2). Since our subjects were studied
just 2.5 hours after injection of allopregnanolone, we think
this could represent a rapid agonistic effect on GABAA mem-
brane receptors coupled to ionic channels [13, 24].The uptake
of glutamate was also decreased by allopregnanolone in the
striatum of control animals (Figure 1). Both glutamate uptake
and release decrement by allopregnanolone administration,
as well as the decrease in the BDNF content in the striatum,
could be due to an inhibitory effect of the neurosteroid on
the glutamatergic corticostriatal pathway [25–28]. If so, it is
possible to speculate that the decrease in the striatal content
of the neurotrophin could be a consequence of GABAergic
activation by allopregnanolone in control animals.
Prenatal administration of ethanol shows that acute
intoxication during GD8 induced long-term changes in the
CNS of the offspring [19]. In this work a similar procedure
was effective in blocking allopregnanolone action on both
glutamate release and BDNF lowering (Figures 1(b) and
2). Allopregnanolone also failed to inhibit the 3H-GABA
release from striatal interneuron, which expresses GABAA
receptors, in ethanol-treated rats. In addition to the mech-
anism described above, this observation could be explained
by a functional alteration of GABAA receptors induced by
prenatal ethanol treatment [8]. This suggestion is based on
behavioral data pointing out that prenatal exposure to ethanol
can alter the GABAA sensitivity to the modulatory effects of
allopregnanolone [8, 29, 30]. Furthermore, it was reported
that prenatal exposure to ethanol can produce long-lasting
alterations in the neuromodulatory influences on GABAA
receptor-mediated transmission, as a consequence of either
differential GABAA receptor subunit expression or receptor
uncoupling [31, 32]. Thus, ethanol-induced alterations in
GABAA subunits expressed in the prefrontal cortex may play
a role in the observed modulatory responses to allopreg-
nanolone. It is possible that both of these mechanisms, one
as a preferential action of allopregnanolone at cortical level
and the other affecting the expression of GABAA receptor
subunits, may contribute to allopregnanolone effects on
glutamate release in ethanol-exposed rats. Since allopreg-
nanolone did not modify striatal BDNF content in these
rats, it might also contribute to restoring the excitatory tone
toward normal values. Whether or not these modifications
are persistent is an issue to be elucidated in the near future.
Altogether the data reported here show that a single dose
of allopregnanolone administrated to control rats inhibited
excitatory neurotransmission and decreased BDNF protein
content at corpus striatum. Ethanol exposure in utero may
produce alterations in GABAA receptors that could explain
the rapid modification in glutamate release and the synthesis
and/or secretion of cortical BDNF. Thus, the effects of
alcohol on GABAA receptors may induce the trophic and
regulatory actions of neurotrophins. Moreover, interactions
between endogenous GABAergic-like neurosteroids such as
allopregnanolone and certain neurotrophins could underlie
mechanisms operating within the brain’s developmental plas-
ticity, giving protection of the fetus against insults such as
ethanol prenatal exposure.
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